Indenolol
 | |
| Names | |
|---|---|
| IUPAC name 1-(1H-Inden-4-yloxy)-3-(propan-2-ylamino)propan-2-ol | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChEMBL |
|
| ChemSpider |
|
| DrugBank |
|
| EC Number |
|
| KEGG |
|
PubChem CID |
|
| UNII |
|
InChI
| |
| |
| Properties | |
Chemical formula | C15H21NO2 |
| Molar mass | 247.338 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Chemical compound
Indenolol is a beta-adrenergic blocker[1] for the treatment of hypertension (high blood pressure). It was investigated in the 1980s,[2] but is not known to be marketed as of 2021[update].[3] It is a derivative of a phenolic 4-indenol.
References
- ^ Ali, I; Gaitonde, VD; Aboul-Enein, HY; Hussain, A (2009). "Chiral separation of beta-adrenergic blockers on CelluCoat column by HPLC". Talanta. 78 (2): 458–63. doi:10.1016/j.talanta.2008.11.043. PMID 19203609.
- ^ Trimarco, Bruno; Cuocolo, Alberto; Groothold, Gisela; Ricciardelli, Bruno; De Luca, Nicola; Volpe, Massimo; Veniero, Anna Maria; Condorelli, Mario (1985). "Indenolol: A New Antihypertensive Agent: Efficacy, Toxicity, and Hemodynamic Effects in a Crossover Double-Blind Study with Metoprolol". The Journal of Clinical Pharmacology. 25 (5): 328–336. doi:10.1002/j.1552-4604.1985.tb02850.x. PMID 4031109. S2CID 22844379.
- ^ DrugBank DB08952 . Accessed 2021-03-18.
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
